169 related articles for article (PubMed ID: 30076956)
21. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
23. Design and evaluation of levodopa methyl ester intranasal delivery systems.
Chun IK; Lee YH; Lee KE; Gwak HS
J Parkinsons Dis; 2011; 1(1):101-7. PubMed ID: 23939261
[TBL] [Abstract][Full Text] [Related]
24. Nano-sized crystalline drug production by milling technology.
Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
[TBL] [Abstract][Full Text] [Related]
25. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
Gaisford S; Dennison M; Tawfik M; Jones MD
Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
[TBL] [Abstract][Full Text] [Related]
26. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
[TBL] [Abstract][Full Text] [Related]
27. Levodopa microparticles for pulmonary delivery: photodegradation kinetics and LC stability-indicating method.
Pereira RL; Paim CS; Barth AB; Raffin RP; Guterres SS; Schapoval EE
Pharmazie; 2012 Jul; 67(7):605-10. PubMed ID: 22888517
[TBL] [Abstract][Full Text] [Related]
28. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
29. Improved Flux of Levodopa via Direct Deposition of Solid Microparticles on Nasal Tissue.
Vasa DM; Buckner IS; Cavanaugh JE; Wildfong PL
AAPS PharmSciTech; 2017 Apr; 18(3):904-912. PubMed ID: 27380436
[TBL] [Abstract][Full Text] [Related]
30. Formulation of a dry powder influenza vaccine for nasal delivery.
Garmise RJ; Mar K; Crowder TM; Hwang CR; Ferriter M; Huang J; Mikszta JA; Sullivan VJ; Hickey AJ
AAPS PharmSciTech; 2006 Mar; 7(1):E131-E137. PubMed ID: 28290034
[TBL] [Abstract][Full Text] [Related]
31. Opportunity and challenges of nasal powders: Drug formulation and delivery.
Tiozzo Fasiolo L; Manniello MD; Tratta E; Buttini F; Rossi A; Sonvico F; Bortolotti F; Russo P; Colombo G
Eur J Pharm Sci; 2018 Feb; 113():2-17. PubMed ID: 28942007
[TBL] [Abstract][Full Text] [Related]
32. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
33. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
34. Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles.
Obaidat RM; Tashtoush BM; Bayan MF; Al Bustami RT; Alnaief M
AAPS PharmSciTech; 2015 Dec; 16(6):1235-44. PubMed ID: 25761387
[TBL] [Abstract][Full Text] [Related]
35. Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure.
Memarvar D; Yaqoubi S; Hamishehkar H; Lam M; Nokhodchi A
Pharm Dev Technol; 2024 Apr; 29(4):353-358. PubMed ID: 38528824
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of mucoadhesive nanosuspension of ciprofloxacin.
Jain V; Kare P; Jain D; Singh R
Acta Pol Pharm; 2011; 68(2):273-8. PubMed ID: 21485301
[TBL] [Abstract][Full Text] [Related]
37. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
[TBL] [Abstract][Full Text] [Related]
38. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
Cai J; Zhang Y; Du W; Nan K
J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
[No Abstract] [Full Text] [Related]
39. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
40. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
